Blueshift Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Blueshift Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,354	Closed	-$231K	–	835
2022 Q1	$231K	Sell	18,354 -3,526	-16%	-$40.4K	0.02%	693
2021 Q4	$255K	Sell	21,880 -3,229	-13%	-$39.6K	0.02%	685
2021 Q3	$328K	Buy	+25,109	New	+$325K	0.02%	774
2020 Q4	–	Sell	-26,748	Closed	-$241K	–	776
2020 Q3	$241K	Buy	+26,748	New	+$266K	0.03%	505
2019 Q3	–	Sell	-16,641	Closed	-$182K	–	835
2019 Q2	$182K	Buy	+16,641	New	+$186K	0.02%	662

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Blueshift Asset Management's IRWD Position: Q2 2022 in Review

Blueshift Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 18,354 shares — an estimated $231K sold.

Blueshift Asset Management first reported a position in IRWD in Q2 2019 and held it in 5 quarters. The position peaked at $328K in Q3 2021. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

Blueshift Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Blueshift Asset Management sold 18,354 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $231K.
Blueshift Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2019 and held it in 5 quarters.
Blueshift Asset Management's Ironwood Pharmaceuticals position peaked at $328K in Q3 2021.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Blueshift Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.